| Literature DB >> 28937591 |
Qian Lu1, Yi-Fan Bu2, Jian-Zhong Liu3.
Abstract
Astaxanthin is a carotenoid of significant commercial value due to its superior antioxidant potential and wide applications in the aquaculture, food, cosmetic and pharmaceutical industries. A higher ratio of astaxanthin to the total carotenoids is required for efficient astaxanthin production. β-Carotene ketolase and hydroxylase play important roles in astaxanthin production. We first compared the conversion efficiency to astaxanthin in several β-carotene ketolases from Brevundimonas sp. SD212, Sphingomonas sp. DC18, Paracoccus sp. PC1, P. sp. N81106 and Chlamydomonas reinhardtii with the recombinant Escherichia coli cells that synthesize zeaxanthin due to the presence of the Pantoea ananatis crtEBIYZ. The B. sp. SD212 crtW and P. ananatis crtZ genes are the best combination for astaxanthin production. After balancing the activities of β-carotene ketolase and hydroxylase, an E. coli ASTA-1 that carries neither a plasmid nor an antibiotic marker was constructed to produce astaxanthin as the predominant carotenoid (96.6%) with a specific content of 7.4 ± 0.3 mg/g DCW without an addition of inducer.Entities:
Keywords: Escherichia coli; astaxanthin; metabolic engineering; β-carotene hydroxylase; β-carotene ketolase
Mesh:
Substances:
Year: 2017 PMID: 28937591 PMCID: PMC5666404 DOI: 10.3390/md15100296
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Pathway for biosynthesizing astaxanthin. DMAPP: Dimethylallyl diphosphate; GPP: Geranyl pyrophosphate; FPP: Farnesyl pyrophosphate; GGPP: Geranylgeranyl pyrophosphate; ispA: FPP synthase gene; crtE: GGPP synthase gene; crtB: Phytoene synthase gene; crtI: Carotene desaturase gene; crtY: Lycopene β-cyclase gene; crtZ: β-carotene hydroxylase gene; crtW: β-carotene ketolase gene.
Effect of the overexpression of different β-carotene ketolase genes on astaxanthin production in Escherichia coli ZEAX.
| Plasmid | OD600 * | Astaxanthin Concentration, mg/L | Astaxanthin Content, mg/gDCW |
|---|---|---|---|
| Single gene | |||
| pZS- | 9.55 ± 0.16 | 8.1 ± 0.1 | 2.7 ± 0.1 |
| pZS- | 8.05 ± 0.47 | 1.3 ± 0.1 | 0.5 ± 0.1 |
| pZS- | 8.61 ± 0.21 | 0.8 ± 0.1 | 0.3 ± 0.1 |
| pZS- | 11.07 ± 0.20 | 5.0 ± 0.2 | 1.4 ± 0.1 |
| Double genes | |||
| pZS-2 | 19.67 ± 0.33 | 28.8 ± 0.2 | 4.6 ± 0.1 |
| pZS-2 | 22.15 ± 0.33 | 20.9 ± 1.6 | 3.5 ± 0.1 |
| pZS-2 | 16.82 ± 0.56 | 7.0 ± 0.1 | 1.3 ± 0.1 |
| pZS-2 | 14.91 ± 0.31 | 1.1 ± 0.6 | 0.2 ± 0.1 |
| Mixed genes | |||
| pZS- | 19.93 ± 0.38 | 12.6 ± 0.6 | 2.0 ± 0.1 |
| pZS- | 21.73 ± 0.19 | 24.6 ± 0.4 | 3.5 ± 0.1 |
| pZS- | 19.9 ± 1.27 | 20.9 ± 1.6 | 3.3 ± 0.1 |
| pZS- | 16.6 ± 0.17 | 8.5 ± 0.2 | 1.6 ± 0.2 |
| pZS- | 20.01 ± 0.12 | 10.5 ± 1.6 | 1.6 ± 0.1 |
| pZS- | 21.57 ± 0.38 | 11.2 ± 0.7 | 1.6 ± 0.1 |
* The OD600 value was expressed as cell growth.
Figure 2HPLC analysis of carotenoid products extracted from E. coli ZEAX (pZS-2crtW) (A), E. coli ZEAX (pZS-2crtW, pBAD-crtZ) (B), E. coli ZEAX (pZS-2crtW, pBAD-crtW) (C), E. coli ZEAX-4 (pZS-2crtW) (D), E. coli ASTA (E), E. coli ASTA-1 (F) and standard astaxanthin (G). 1. astaxanthin; 2. Phoenicoxanthin; 3. Canthaxanthin; 4. Lycopene.
Astaxanthin production by different microorganisms.
| Strain | Astaxanthin Yield | Astaxanthin Ratio (%) | Reference |
|---|---|---|---|
| 5.8 mg/g DCW | N.D. * | [ | |
| 8.64 mg/g DCW | N.D. | [ | |
| 1.4 mg/g DCW | 95 | [ | |
| 1.99 mg/g DCW | 90 | [ | |
| 7.4 ± 0.3 mg/g DCW | 96.6 | This study | |
| 4.7 mg/g DCW | N.D. | [ | |
| 8.10 mg/g DCW | N.D. | [ | |
| 0.4 mg/L/h | N.D. | [ |
* N.D. = not determined.
Strains and plasmids used in this study.
| Name | Description | Reference/Sources |
|---|---|---|
| Strain | ||
| β-Carotene producing strain | [ | |
| Zeaxanthin producing strain, one copy of | [ | |
| Zeaxanthin producing strain, two copies of | This study | |
| Astaxanthin producer, one of | This study | |
| Astaxanthin producer, another copy of | This study | |
| Plasmid | ||
| pZSABP | Constitute expression vector, pSC101 | [ |
| pBAD33 | Expression vector, PBAD, p15A | [ |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS-2 | pZSABP containing two copies of | This study |
| pZS-2 | pZSABP containing two copies of | This study |
| pZS-2 | pZSABP containing two copies of | This study |
| pZS-2 | pZSABP containing two copies of | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pZS- | pZSABP containing | This study |
| pBAD- | pBAD33 containing | This study |
| pBAD- | pBAD33 containing | This study |